icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Age-Related Co-Morbidities and Polypharmacy in HCV-Infected Patients With Substance Use Disorders Treated With G/P: A Real-World Analysis From 9 Countries
 
 
  AASLD Nov 11-16 virtual
Reported by Jules Levin
 
Dominque Larrey1, Massimo Puoti2, Anna Piekarska3, David Back4, Fiona Marra4, Mark Bondin5, Ritu Raheja5, Zhenzhen Zhang5, Hari V Kalluri5, John Marcinak5, Carlos Roncero61Hepato-Gastroenterologie, H˘pital Saint-Eloi, Montpellier, France; 2Niguarda ca Grande Hospital, Milan, Italy; 3Infectious Diseases and Hepatology Department, Medical University of Lodz, Lodz, Poland; 4Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom; 5AbbVie Inc, North Chicago, Illinois, United States; 6Psychiatry Service, University of Salamanca Health Care Complex, Institute of Biomedicine, University of Salamanca, and Psychiatry Unit, School of Medicine, University of Salamanca, Salamanca, Spain

1116201

1116202

1116203

1116204

1116205

1116206

1116207

1116208

1116209

11162010

11162011

11162012

11162013

11162014